Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement
Authors
Keywords
PEG, Anti-PEG antibodies, Complement, Liposomes, LNPs
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 341, Issue -, Pages 475-486
Publisher
Elsevier BV
Online
2021-12-08
DOI
10.1016/j.jconrel.2021.11.042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 Cells
- (2021) Monika Bednarczyk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The tangled history of mRNA vaccines
- (2021) Elie Dolgin NATURE
- The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation
- (2020) Thai Thanh Hoang Thi et al. Polymers
- Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex
- (2020) Even Chen et al. ACS Nano
- Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
- (2020) Gergely Tibor Kozma et al. ADVANCED DRUG DELIVERY REVIEWS
- ARGX-117, a therapeutic complement inhibiting antibody targeting C2
- (2020) Inge Van de Walle et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Maintaining Safety with SARS-CoV-2 Vaccines
- (2020) Mariana C. Castells et al. NEW ENGLAND JOURNAL OF MEDICINE
- PEGylated liposomes: immunological responses
- (2019) Marwa Mohamed et al. SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
- Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker
- (2019) Robin Kloos et al. BRITISH JOURNAL OF HAEMATOLOGY
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
- (2019) Akin Akinc et al. Nature Nanotechnology
- Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes
- (2018) Yuan-Chin Hsieh et al. Theranostics
- The mystery behind membrane insertion: a review of the complement membrane attack complex
- (2017) Charles Bayly-Jones et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Liposomal Formulations in Clinical Use: An Updated Review
- (2017) Upendra Bulbake et al. Pharmaceutics
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- Robust, tumor-homing and redox-sensitive polymersomal doxorubicin: A superior alternative to Doxil and Caelyx?
- (2016) Yan Zou et al. JOURNAL OF CONTROLLED RELEASE
- Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
- (2016) Peng Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Relationship between the Concentration of Anti-polyethylene Glycol (PEG) Immunoglobulin M (IgM) and the Intensity of the Accelerated Blood Clearance (ABC) Phenomenon against PEGylated Liposomes in Mice
- (2015) Yosuke Hashimoto et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells
- (2015) Taro Shimizu et al. IMMUNOBIOLOGY
- Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein
- (2015) Yu Mima et al. MOLECULAR PHARMACEUTICS
- Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
- (2014) Johan J.F. Verhoef et al. DRUG DISCOVERY TODAY
- The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
- (2013) Amr S. Abu Lila et al. JOURNAL OF CONTROLLED RELEASE
- Liposome: classification, preparation, and applications
- (2013) Abolfazl Akbarzadeh et al. Nanoscale Research Letters
- Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
- (2012) Ricardo P Garay et al. Expert Opinion on Drug Delivery
- Accelerated Blood Clearance of Pegylated Liposomal Topotecan: Influence of Polyethylene Glycol Grafting Density and Animal Species
- (2012) Chunlei Li et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
- (2011) Paola Milla et al. CURRENT DRUG METABOLISM
- Membrane attack by complement: the assembly and biology of terminal complement complexes
- (2011) Cosmin A. Tegla et al. IMMUNOLOGIC RESEARCH
- Role of complement in innate immunity and host defense
- (2011) Leendert A. Trouw et al. IMMUNOLOGY LETTERS
- Nanoparticle PEGylation for imaging and therapy
- (2011) Jesse V Jokerst et al. Nanomedicine
- Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome
- (2011) János Szebeni et al. Nanomedicine-Nanotechnology Biology and Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now